At the same time, existing biochemical techniques are advancing to enhance the process of biotechnological research. X-ray crystallography and combinatorial chemistry are two examples of increased modernization. As discovery technologies more quickly determine greater numbers of targets, greater numbers of compounds will be reaching the clinical trial phase of development sooner.

The clinical trial is that segment of research in the drug development process that tests a product or device to determine such factors as safety, efficacy, and adverse reactions in a human population. This report will focus on the following:

Research and development of drugs and biologics and new applications for old drugs and devices

Major product pipelines in development for the top biotechnology and pharmaceutical companies

The impact of new technologies on the costs and processes of clinical trials. 

This report also addresses current and future trends in clinical trial research, how new focuses are driven by epidemiological trends, treatment of rare diseases, and the threat of bioterrorism.

INTENDED AUDIENCEThis report provides a thorough background of the clinical trial process. It is an invaluable tool for business planners, acquisitions specialists, licensing strat
'/>"/>